LEMAITRE VASCULAR, INC. (LMAT) Net margin 2016–2025
LEMAITRE VASCULAR, INC. (LMAT) net profit margin by fiscal year — reported net income divided by reported revenue.
23.1%FY2025 · since FY2016: 11.9% → 23.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 23.1% | +3.1 pp |
| FY2024 | 20.0% | +4.5 pp |
| FY2023 | 15.6% | +2.8 pp |
| FY2022 | 12.7% | -4.7 pp |
| FY2021 | 17.4% | +1.0 pp |
| FY2020 | 16.4% | +1.1 pp |
| FY2019 | 15.3% | -6.4 pp |
| FY2018 | 21.7% | +4.7 pp |
| FY2017 | 17.0% | +5.2 pp |
| FY2016 | 11.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice